My title
» GU Cancer

GU Cancer

PROSTATE CANCER CLINICAL TRIALS

Study Link Study Status Study Title Principal Investigator
ARAMIS3104007 Active-Enrolling A Multinational, Randomised, Double-Blind, Placebo-Controlled, Phase III Efficacy And Safety Study Of Odm-201 In Men With High-Risk Non-Metastatic Castration-Resistant Prostate Cancer PI: Jason Taksey
RTOG / 0924 Active-Enrolling Androgen Deprivation Therapy and High Dose Radiotherapy with or without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial  PI: Angel Torano

 

Our Studies